Diabetes: T1DM, T2DM, Management, Complications Flashcards

1
Q

Describe the

  • epidemiology, etiology
  • pathophysiology and associations
A

T1 - common in younger people (HLA DR3-4)
-AI destruction of beta cells => no insulin produced
T2 - common in obese
-relative deficiency of insulin

Metabolic syndrome 
-diabetes mellitus
-HTN 
-dyslipidaemias
-obesity
predisposes to macrovascular (strokes, PAD, CHD) and microvascular (neuropathy, nephropathy)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Presentation

A

T2 is often asymptomatic

  • frequent UTIs, skin, candida infections
  • physical inactivity, CV risk factors

Symptomatic

  • fatigue
  • polyuria, polydipsia, polyphagia, nocturia
  • weightloss
  • visual changes

Emergency presentations

  • polyuria, polydipsia => dehydration, shock
  • confusion, fatigue

DKA

  • acidosis => N+V, abdo pain,
  • Kussmaul breathing

HHS

  • no acidosis
  • shallow breaths
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Investigations, diagnosis for T1DM, T2DM

A

Diagnostic criteria

  • Symptomatic RPG or GTT => 11mmol/L+
  • FPG => 7mmol/L+

HbA1c => 48mmol/mol+ or 6.5%+
-use other measures if HbA1c likely to be unhelpful

Glucose tolerance test

  • Fast for 8-10hours before test
  • Measure BG 2hrs after 75g oral glucose

If symptomatic - single abnormal reading can be used but repeat testing is sensible
If asymptomatic, repeat test to confirm

Not routinely done for T1DM

  • Cpeptide - low
  • Urinary ketones
  • GAD, Islet antigen, ZnT8
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Management - lifestyle

A

Will be supported with self monitoring

  • Balanced diet, smoking cessation, physical activity to reduce CV risks
  • Alcohol reduction - cause hyperglycemia, potentiate hypoglycemic effects of insulin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q
What are the target glucose readings
-on waking
-before meals
-after meals
HbA1c
A

On waking 5-7
Before meals 4-7
After meals 5-9

HbA1c under 6.5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe how you might dose insulin

-how might you support this

A

Basal bolus - short and long acting injected separately
Mixed regimen - fewer injections as short and long acting are mixed together
Continuous insulin pump

When changing a dosing plan, always

  • look for any hypos
  • look for any patterns
  • change the insulin dose before that reading and make 1 change at a time
  • if changing a dose before bed, monitor the 3am reading first

DAFNE programme, learn how to adjust insulin around diet

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe how you would manage T2DM

-medically

A
1st LINE - metformin
-DPP4inh if metformin not tolerated
2nd LINE - dual therapy
3rd LINE - triple therapy
-DPP4inh (-gliptin)/sulfonylurea(-ide)/SGLT2inh (-glifozin)
Last line - insulin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe the

  • presentation
  • investigations for DKA
A

Presentation within hours

  • polyuria, polydipsia, N+V => dehydration
  • abdo pain
  • fatigue, confusion, blurry vision
  • Kussmaul breathing, ketotic breath

DEFINITIVE

  • Urinalysis 2+ OR Blood ketone 3mmol/L+
  • Blood glucose 11mmol/L+
  • HCO3 U15mmol/L OR acidotic pH
  • U&E - hyperkalemia (5+)
  • FBC - high WBC if infective cause

Investigations to consider if trying to find cause

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

DKA management

A
  1. FLUID RESUS
    - 500ml saline bolus in 15mins if hypotensive
    - 1000ml saline bolus in 60mins if normotensive
  2. INSULIN TO CORRECT ACIDOSIS
    - K will fall, monitor this
  3. K INFUSION (hyperkalemia results from acidosis but lost in diuresis)
  4. REASSESS PATIENT AND IDENTIFY CAUSE
  5. MONITOR FOR ARRYTHMIAS, CEREBRAL EDEMA
    - VTE prophylaxis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe the

  • presentation
  • investigations for HHS
A

Presentation over several days

  • polyuria, polydipsia => dehydration, shock
  • confusion, fatigue
  • no acidosis or ketosis
  • shallow breaths

Investigations

  • hypovolaemia
  • hyperglycaemia (30+) without ketones (U3) or metabolic acidosis (HCO3 15+)
  • hyperosmolality (>320 mOsm/kg)

Investigations to consider if trying to find cause

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

HHS management

A
  1. FLUID RESUS
    - 500ml saline bolus in 15mins if hypotensive
    - 1000ml saline bolus in 60mins if normotensive
  2. INSULIN TO CORRECT GLUCOSE
    - at a lower rate than DKA

3.REASSESS PATIENT AND IDENTIFY CAUSE

  1. MONITOR FOR ARRYTHMIAS, CEREBRAL EDEMA
    - VTE prophylaxis -LWMH
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe the

  • presentation
  • investigations for hypoglycemia
A

Early presentation - glucagon => adrenaline => cortisol release

  • hunger, fatigue
  • shaking, pale, sweating
  • headache, dizziness

Late presentation

  • confusion
  • slurred speech, blurred vision
  • fainting, seizures, coma

Investigations for hypoglycemia
-BG U3.5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How would you manage hypoglycemia

  • conscious and can swallow
  • unconcious
A

Conscious and can swallow

  • 3-6 glucose tablets/50-100ml lucozade/4 jelly babies/7 jelly beans
  • recheck BG after 15mins and repeat oral intake if inadequate response
  • when symptoms improve, eat long acting carbs to maintain BG

Unconscious, no swallow, confused

  • IM glucagon
  • if no response or unable to give glucagon => 999
  • once responsive => oral carbohydrates
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Insulin

  • mode of administration
  • side effects
A

SC - Acts on NaKATPase
Increases adipose, muscle glucose uptake
Inhibits liver glucose release

SC

  • Lipohypertrophy => erratic insulin uptake
  • Hypoglygemia, weight gain
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Metformin

  • mode of administration
  • positive effects
  • side effects
  • CI
A

PO - Biguanide - increases insulin sensitivity

  • Decreases hepatic gluconeogenesis
  • Decrease GI uptake of carbohydrates

No hypoglycemia, weight loss

GI upsets (N+V+D+A)
Reduced B12 uptake
Lactic acidosis

CKD (renal excretion)
Use of radiocontrast
Tissue hypoxia => increases lactic acidosis risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

GLP1s vs DPP4inh

  • mode of administration
  • positive effects
  • side effects
A

GLP1
SC -tide
Increase insulin, decrease glucagon
-weight loss, no hypoglycemia

DPP4inh
PO -gliptin
Increase levels of GLP1, GIP by decreasing peripheral breakdown of incretins
-weight neutral, no hypoglycemia

SE of both

  • GI upset (N+V)
  • Pancreatitis
17
Q

Sulphonyureas

  • mode of administration
  • side effects
A

PO - Stimulate B cells

  • hypoglycemia, weight gain
  • Hyponatremia (due to KATPase blocking => depolarisation and insulin release)
  • Reduced efficacy over time
18
Q

How would you screen for diabetic complications

A

Retinopathy - vitreous hemorrhage

  • low risk - every 2 years
  • higher risk - annually

Foot and neuopathy

  • annually for low risk
  • peripheral neuropathy (painful, sensorimotor), PAD => ulceration, foot deformity, poor hygiene
  • autonomic neuropathy (multiple systems, gradual onset) => postural hypotension, urinary/fecal incontinence, diarrhoea

Nephropathy - CKD
-annually

CV - QRISK

  • lifestyle advice, physical activity
  • HTN => lifestyle advice, ACEi/ARB
  • Cholesterol => atorvastatin